Description

Acipimox CAS NO 51037-30-0 is a potent nicotinic acid derivative and a key pharmaceutical intermediate. This compound is valued for its role in the synthesis of lipid-regulating agents, specifically as an active pharmaceutical ingredient (API) for treating hyperlipidemia. It is essential for manufacturers in the pharmaceutical and fine chemical sectors requiring high-purity building blocks for metabolic disorder therapeutics.

Application

• Primary use as an Active Pharmaceutical Ingredient (API) in the formulation of anti-hyperlipidemic drugs.
• Critical pharmaceutical intermediate for the synthesis of advanced lipid-lowering compounds.
• Used in research and development of new therapeutic agents targeting metabolic syndromes.
• Reference standard in analytical laboratories for quality control and method validation.
• Starting material for the preparation of derivatives with potential enhanced pharmacological profiles.

Basic Information

Item	Detail
Product Name	Acipimox
CAS No.	51037-30-0
Molecular Formula	C6H6N2O3
Molecular Weight	154.12 g/mol
Synonyms	5-Methylpyrazine-2-carboxylic acid 4-oxide; Olbetam; K-9321; Acipimoxum; 5-Methylpyrazinecarboxylic acid 4-oxide; 2-Pyrazinecarboxylic acid, 5-methyl-, 4-oxide; 5-Methyl-2-pyrazinecarboxylic acid 1-oxide
EINECS	Contact for details

Quality Control

Our Acipimox is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation (IR), to ensure it meets exacting standards suitable for pharmaceutical use. A detailed Certificate of Analysis (COA) is provided with every shipment, and we can support compliance with cGMP, ICH Q7, and other relevant regulatory guidelines upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Assay (HPLC)	≥ 98.5%
Related Substances (HPLC)	Total impurities ≤ 1.5%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.